Last updated: September 22, 2025
Sponsor: Institut Mutualiste Montsouris
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia (Local)
Treatment
Ultrasound guided supra inguinal fascia iliaca block
Placebo Injection
Surgical and anesthetic protocol
Clinical Study ID
NCT06982625
ANESTH-03-2024
2024-A02290-47
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
patient scheduled for a primary total hip arthroplasty under general anesthesia,
written informed consent.
Non inclusion criteria:
contra indication to ropivacaine
vulnerable person
Exclusion
Exclusion Criteria:
per-operative complication making wheight-bearing and walking contra-indicated.
patient without significant pain post-operatively.
Study Design
Total Participants: 310
Treatment Group(s): 3
Primary Treatment: Ultrasound guided supra inguinal fascia iliaca block
Phase:
Study Start date:
September 22, 2025
Estimated Completion Date:
December 31, 2027
Connect with a study center
Institut Mutualiste Montsouris
Paris 2988507, 75014
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.